"Adricin" or Doxorubicin (Dox) is an anthracycline antibiotic agent used in the treatment of solid and haematopoietic tumors, but it
has cardiac, renal and hepatic toxicities. Oxidative stress has an important role in the pathogenesis of Dox- toxicity. This study
investigated the role of Ferulic acid (FA), a natural antioxidant agent, in protection against Doxorubicin-induced toxicity. 40 albino
rats were used, and divided into four groups, Group I (control group), Group II: Dox intraperitoneal for two weeks. Group III: Ginkgo
biloba (GB) + Dox, Group IV: FA +Dox. Biochemical assays for serum creatinine, serum lactate dehydrogenase, creatine
phosphokinase, AST and ALT were done. Immuno histochemistry examination of the kidneys, heart and liver and the levels of MDA,
GSH, SOD and catalase were assessed. Results: Treatment with FA resulted in improvement of oxidative stress, and decrease in
expression of NF-κB, that may be a promising natural adjuvant therapy, potentially ameliorating Dox toxicity in clinical practice.
Conclusion: FA can be considered a good candidate for offering protection against the deleterious toxicity of Dox.
Keywords: Dox toxicity, Ferulic acid, Doxorubicin, Oxidative stress